Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
4.265
-0.115 (-2.63%)
At close: Nov 13, 2026, 4:00 PM EST
4.190
-0.075 (-1.76%)
After-hours: Nov 13, 2026, 7:30 PM EST

Revelation Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-12.71-9.07-7.98-8.66-10.86-11.95
Net Income
-17.84-14.87-15.04-0.12-10.83-11.99
Earnings Per Share
-39.98-167.62----
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.1210.76.511.995.251.27
Total Debt
0.810.75---0.02
Net Cash (Debt)
8.329.956.511.995.251.26
Net Cash Growth
-34.56%53.15%-45.80%128.28%317.57%-72.00%
Net Cash Per Share
18.63112.24----

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.1-8.27-18.32-7.29-11.22-11.09
Capital Expenditures
-0.11--0.02---0.13
Free Cash Flow
-10.21-8.27-18.34-7.29-11.22-11.22
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.